Binge alcohol drinking has emerged as a typical phenomenon in young people. This pattern of drinking, repeatedly leading to extremely high blood and brain alcohol levels and intoxication is associated with severe risks of neurodegeneration and cognitive damage. Mechanisms involved in excitotoxicity and neuroinflammation are pivotal elements in alcohol-induced neurotoxicity. Evidence has demonstrated that PPARc receptor activation shows anti-inflammatory and neuroprotective properties. Here we examine whether treatment with the PPARc agonist pioglitazone is beneficial in counteracting neurodegeneration, neuroinflammation and cognitive damage produced by binge alcohol intoxication. Adult Wistar rats were subjected to a 4-day binge intoxication procedure, which is commonly used to model excessive alcohol consumption in humans. Across the 4-day period, pioglitazone (0, 30, 60 mg/kg) was administered orally twice daily at 12-h intervals. Degenerative cells were detected by fluoro-jade B (FJ-B) immunostaining in brain regions where expression of pro-inflammatory cytokines was also determined. The effects of pioglitazone on cognitive function were assessed in an operant reversal learning task and the Morris water maze task. Binge alcohol exposure produced selective neuronal degeneration in the hippocampal dentate gyrus and the adjacent entorhinal cortex. Pioglitazone reduced FJ-B positive cells in both regions and prevented alcohol-induced expression of pro-inflammatory cytokines. Pioglitazone also rescued alcoholimpaired reversal learning in the operant task and spatial learning deficits in the Morris water maze. These findings demonstrate that activation of PPARc protects against neuronal and cognitive degeneration elicited by binge alcohol exposure. The protective effect of PPARc agonist appears to be linked to inhibition of pro-inflammatory cytokines.
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Introduction
Chronic alcohol intoxication resulting from binge drinking results in significant activation of neurodegenerative processes (Vetreno and Crews, 2015; Vetreno et al., 2016) . The alcoholic brain shows reduction in brain volume and weight, enlargement of ventricles and gray as well as white matter shrinkage in cortical and subcortical structures (Pfefferbaum et al., 1992; Vetreno and Crews, 2015) . Alcohol-induced neuropathological alterations in brain structure and function are often correlated with impairments in cognitive processes (Bowden and McCarter, 1993; White, 2003) . In laboratory animals, it is well established that large doses of alcohol (11-15 g/kg/day) administered over a short period of time (4 days) reliably produce neurotoxicity in various corticolimbic areas including the hippocampal dentate gyrus (DG) and the entorhinal cortex [EC, (Collins et al., 1996; Crews et al., 2004; Obernier et al., 2002a) ]. The binge model of human alcoholic neurodegeneration, which mimics a single cycle of binge intoxication in human alcoholics (Braconi et al., 2010) , is further validated by the fact that during alcohol intoxication animals reach sustained, high blood alcohol levels (BALs), commonly observed among alcoholics. Furthermore, neuronal deficits in animals treated with this http://dx.doi.org/10.1016/j.bbi.2017.02.001 0889-1591/Ó 2017 Elsevier Inc. All rights reserved.
